ICD-10-CM Code For Secondary Neuroendocrine Tumors: Group Overview
The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C7B includes metastatic neuroendocrine tumors and related secondary neuroendocrine neoplasms that have spread from a primary neuroendocrine site to other organs. These ICD-10-CM diagnosis codes are used to document metastatic disease, organ involvement, and disease burden when neuroendocrine tumors are not primary at the site of diagnosis. Accurate coding within the ICD-10-CM C7B group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.
Customize your policy alerts
Sign up for ICD-10-CM Code For Secondary Neuroendocrine Tumors: Group Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
ICD-10-CM C7B: Secondary Neuroendocrine Tumors Overview
This code group represents metastatic neuroendocrine tumors that originated in one part of the body and spread to other organs. These diagnoses target malignant neuroendocrine neoplasms affecting multiple organ systems, commonly liver, lung, or bones. Accurate coding is important for clinical tracking and supports appropriate reimbursement for treatments and care coordination.